Considering the possible function of galectin-7 expression in activating cell necrosis in ccRCC, it may be targeted to decrease necrosis, lower inflammatory burden [31] in ccRCC and improve patients survival. Here, LGALS7 is linked to nonpapillary renal cell carcinoma.